Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Jose-Alberto Palma, MD, PhD is a physician-scientist with over fifteen years of experience in clinical trials and drug development, dedicated to advancing medical research and patient care. From 2015 to 2020, he worked as a principal investigator of neurodegeneration clinical trials at New York University (NYU) Grossman School of Medicine. In 2020, he transitioned to the pharmaceutical industry, taking on the global clinical trial lead role for neurodegeneration programs at Novartis, and continued this work at Eli Lily from 2023 onwards.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Housing Works Online Bookstore, New York, NY, USA
Zustand: Very Good. Minimal wear to cover. Pages clean and binding tight. shelf wear. bumped edges. Hardcover. Bestandsnummer des Verkäufers KB3-01075
Anzahl: 1 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 52108665-n
Anzahl: 4 verfügbar
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
Hardback. Zustand: New. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This gap is not merely due to a lack of interest; the clinical trial process can be daunting, often leaving patients and their families uninformed, unprepared and overwhelmed. This book offers a much-needed, clear, balanced, and comprehensive guidance at a moment when patient-centered care has never been more important. It demystifies how trials work, what patients can expect, and how to weigh the promise of cutting-edge treatments against the challenges and potential risks involved. It simultaneously empowers patients and caregivers to make informed decisions, turning a process that can feel intimidating into one that is understandable, navigable, and ultimately hopeful. Bestandsnummer des Verkäufers LU-9798881842475
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers GB-9798881842475
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Bestandsnummer des Verkäufers 6YIVBEVTGH
Anzahl: 5 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 52108665
Anzahl: 4 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers GB-9798881842475
Anzahl: 3 verfügbar
Anbieter: Rarewaves USA, OSWEGO, IL, USA
Hardback. Zustand: New. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This gap is not merely due to a lack of interest; the clinical trial process can be daunting, often leaving patients and their families uninformed, unprepared and overwhelmed. This book offers a much-needed, clear, balanced, and comprehensive guidance at a moment when patient-centered care has never been more important. It demystifies how trials work, what patients can expect, and how to weigh the promise of cutting-edge treatments against the challenges and potential risks involved. It simultaneously empowers patients and caregivers to make informed decisions, turning a process that can feel intimidating into one that is understandable, navigable, and ultimately hopeful. Bestandsnummer des Verkäufers LU-9798881842475
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This gap is not merely due to a lack of interest; the clinical trial process can be daunting, often leaving patients and their families uninformed, unprepared and overwhelmed. This book offers a much-needed, clear, balanced, and comprehensive guidance at a moment when patient-centered care has never been more important. It demystifies how trials work, what patients can expect, and how to weigh the promise of cutting-edge treatments against the challenges and potential risks involved. It simultaneously empowers patients and caregivers to make informed decisions, turning a process that can feel intimidating into one that is understandable, navigable, and ultimately hopeful. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9798881842475
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 52108665-n
Anzahl: 4 verfügbar